methylene blue has been researched along with Protein Aggregation, Pathological in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Pavlov, PF; Wang, L; Winblad, B | 1 |
| Antosova, A; Bednarikova, Z; Cheng, YH; Gazova, Z; How, SC; Lai, JT; Lin, TH; Lo, CH; Wang, SS; Wu, JW | 1 |
| Baddeley, TC; Cheung, JK; Harrington, CR; Horsley, D; McCaffrey, J; Melis, V; Storey, JM; Wischik, CM | 1 |
| Clunas, S; Harrington, CR; Harrington, KA; Horsley, D; Ishaq, A; Kemp, SJ; Larch, CP; Marshall, C; Nicoll, SL; Rickard, JE; Simpson, M; Sinclair, JP; Storey, JM; Storey, LJ; Wischik, CM | 1 |
| Bakota, L; Brandt, R | 1 |
2 review(s) available for methylene blue and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
Topics: Alzheimer Disease; Animals; Benzodioxoles; Cholinesterase Inhibitors; Cholinesterases; Curcumin; Humans; Molecular Targeted Therapy; Neurofibrillary Tangles; Neuroprotective Agents; Phosphorylation; Plaque, Amyloid; Protein Aggregation, Pathological; Protein Processing, Post-Translational; Quinazolines; Receptors, N-Methyl-D-Aspartate; tau Proteins; Thiadiazoles | 2021 |
Tau Biology and Tau-Directed Therapies for Alzheimer's Disease.
Topics: Alzheimer Disease; Epothilones; Humans; Immunization, Passive; Methylene Blue; Molecular Targeted Therapy; Oligopeptides; Protein Aggregation, Pathological; tau Proteins | 2016 |
1 trial(s) available for methylene blue and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease.
Topics: Absorption, Physicochemical; Administration, Oral; Adolescent; Adult; Alzheimer Disease; Animals; Biological Transport; Brain; Dose-Response Relationship, Drug; Eating; Erythrocytes; Female; Humans; Male; Methylene Blue; Mice; Oxidation-Reduction; Protein Aggregation, Pathological; tau Proteins; Young Adult | 2015 |
2 other study(ies) available for methylene blue and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Exploring the effects of methylene blue on amyloid fibrillogenesis of lysozyme.
Topics: Amyloid; Amyloidosis; Methylene Blue; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Muramidase; Protein Aggregates; Protein Aggregation, Pathological; Protein Binding; Spectrum Analysis; Structure-Activity Relationship | 2018 |
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease.
Topics: Alzheimer Disease; Animals; Brain; Cell Line; Humans; Methylene Blue; Mice; Mice, Transgenic; Models, Biological; Protein Aggregates; Protein Aggregation, Pathological; Protein Interaction Domains and Motifs; Proteolysis; Recombinant Proteins; tau Proteins | 2015 |